Industry Outlook
The nutrigenomics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 portraying excellent growth with a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO), by 2020 chronic diseases will be responsible for 73% of the total global deaths associated with obesity, diabetes, cardiovascular complications and cancer. Technological advancement in the IT healthcare segment and DNA quantification techniques have a positive impact on the nutrigenomics market growth. The limitations associated with this market are dearth of trained healthcare professionals and bacterial contamination associated with saliva and buccal swab collection methods.
Market Synopsis
Get a sample copy for more information
"Rampant growth in clinical laboratories and availability of diverse range of test kits drive the reagents and kits market"
Reagents and kits are currently leading the product segment for nutrigenomics market. The key features responsible for the magnificent growth of reagents and kits are rampant growth of clinical laboratories and rising public health awareness regarding chronic diseases. Services will garner impressive growth during the forecast period on account of rapidly growing IT healthcare services such as electronic health records of patients (EHR) and user friendly portable healthcare apps for ailing patients.
Get a sample copy for more information
"Increasing demand for fast food and unhealthy lifestyle are responsible for the rapid growth of obesity throughout the globe"
Obesity is currently dominating the application segment for nutrigenomics market. The factors responsible for the rapidly growing obesity worldwide are engineered junk food, insulin resistance, leptin resistance, stress, sedentary lifestyle etc. Arduous research studies have linked genetic factors with obesity and hence nutrigenomics is helpful in finding alternative to fight the socio-economic burden associated with obesity. Nutrigenomics is considered as a personalized therapy wherein nutritional requirement varies according to individuals. Chronic disease will be showcasing significant growth on account of factors such as poor nutrition in daily intake of diet and unhealthy lifestyle which trigger genetic anomaly eventually constructing disease etiology related to chronic disease.
"Buccal swabs are the most preferred test due to its quick, non-invasive procedure and less pain associated with the sample collection"
The study of nutrigenomics is highly dependent on the DNA sample collected from the patient. Buccal swabs and blood samples are being used for collecting the DNA, the only difference lies in how they are processed while studying nutrigenomics of a patient. Buccal swab kits are available in diverse varieties where in the consumer can personally extract DNA rich cells using the buccal swabs and place in a dry and sterile container and directly ship it to the concerned laboratories. This method is very quick, non-invasive and less painful. Scientist are finding innovative ways to prevent the effect of bacterial contamination in buccal swabs which reduces the stability of the DNA in the collected sample. Blood samples are the most traditional and reliable methods of collecting DNA samples. Venipuncture and pain associated with sample collection make them less popular in comparison to other collection methods. Other non-invasive methods such as hair and urine samples are gaining popularity due to lower sample volume requirement, good storage and DNA quantification ability of polymerase chain reaction (PCR) method.
Get a sample copy for more information
"Sedentary lifestyle and increasing public health awareness are responsible for the growth of Nutrigenomics market in North America"
In the current scenario North America with a share of 40% is leading the regional segment for Nutrigenomics market. The factors responsible for the growth of Nutrigenomics market in North America are sedentary lifestyle giving rise to chronic diseases such as obesity and diabetes. Increasing public health awareness and presence of well-developed nutrition science health department drive the Nutrigenomics market in North America. As per the latest research citing of European Center for Disease Control and Prevention (ECDC), 85% of all the deaths recorded in the region are due to chronic diseases such as diabetes, cardiovascular, cancer etc. The government healthcare agencies have formed strategic alliances with academia research centers to improve the quality of nutrition in daily diet in order to decrease the burden associated with chronic diseases. Asia Pacific will record a substantial growth during the forecast period from 2018 to 2026 on account of rising prevalence of chronic disease, malnutrition and poverty. Government healthcare agencies are fighting to curb malnutrition and provide nutritional diet to the poverty stricken population. Traditional herbs and medicines are being studied thoroughly in order to extract their active ingredients to fight chronic diseases.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
For the scope of the report the market segmented is as follows:
| ATTRIBUTE |
DETAILS |
| Research Period |
2016-2026 |
| Base Year |
2017 |
| Forecast Period |
2018-2026 |
| Historical Year |
2016 |
| Unit |
USD Million |
| Segmentation |
By Product (2016–2026; US$ Mn)
• Services
• Reagents and Kits
|
|
By Application (2016–2026; US$ Mn)
• Diabetes
• Obesity
• Chronic Diseases
• Others
|
|
By Test (2016–2026; US$ Mn)
• Saliva Test
• Buccal Swab Test
• Blood Test
• Others
|
|
Geography Segment (2016–2026; US$ Mn)
• North America (United States and Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
Pharmaceutical companies providing reagents and kits to determine the nutrigenomics of human beings are Cura Integrative Medicine, Centogene, Genomix Nutrition, Inc., Metagenics, Inc., NutraGene, Nutrigenomix, Navigenics, XCODE Life Sciences, Pvt. Ltd., WellGen, Inc. and 23&Me, Inc.
Key questions answered in this report
- How the market assessment is performed and current market trends is determined?
- Who are the leading players providing nutrigenomics reagents and kits?
- Which is the largest and fastest growing product segment for nutrigenomics market?
- Which is the largest and fastest growing application segment for nutrigenomics market?
- Which is the largest and fastest growing test segment for nutrigenomics market?
- Which is the largest and fastest growing geographical segment for nutrigenomics market?
